| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |